Timely Recognition of d-Transposition of the Great Arteries: Medical Considerations in Evaluating Standards of Care

Introduction

d-Transposition of the great arteries (d-TGA) is the most common cyanotic congenital heart defect presenting in the neonatal period, accounting for approximately 5–7% of all congenital heart disease. Without intervention, mortality approaches 85–90% during the first year of life. With timely diagnosis and modern surgical repair — the arterial switch operation — survival now exceeds 95% in many centers, and the majority of children go on to lead productive lives.

Despite these advances, delayed recognition of d-TGA continues to occur. When the diagnosis is missed, affected neonates are exposed to prolonged, severe oxygen deprivation that can damage the brain, heart, kidneys, and other organs. Delayed diagnosis may also precipitate cardiovascular collapse and death. For these reasons, cases involving delayed recognition of d-TGA remain among the most significant areas of pediatric medical malpractice litigation.

Evaluating such cases requires a careful understanding of the underlying cardiac anatomy and physiology, the expected clinical presentation, the current recommendations for newborn screening, the available diagnostic tools, and the known relationship between timing of diagnosis and clinical outcomes. This article provides an evidence-based overview of these topics to help attorneys, insurers, and healthcare organizations navigate the medical complexity of d-TGA litigation with accuracy and confidence.

It is important to note at the outset that not every delayed diagnosis represents a deviation from the standard of care, and not every deviation from the standard of care results in harm. These are distinct medical and legal questions that require independent analysis.

Clinical Vignette

The following case is entirely fictional and is presented solely for educational purposes.

Baby M is a full-term male infant born at a community hospital at 39 weeks' gestation via uncomplicated vaginal delivery. Birth weight is 3,400 grams. Apgar scores are 8 and 9 at one and five minutes, respectively. The infant appears well and is rooming in with his mother.

At 12 hours of life, a nurse notes that Baby M appears slightly dusky during feeding. The infant is described as a "slow feeder." The on-call physician is notified and examines the infant. The cardiac examination reveals a single loud second heart sound but no murmur. The physician attributes the color change to normal transitional circulation and documents "appears well, feeding adequately."

Pulse oximetry screening is not performed. No further evaluation is ordered.

Baby M is discharged home at 36 hours of life.

Over the following three days, the infant's parents notice worsening color changes, poor feeding, and increased work of breathing. They bring the infant to the emergency department on day of life four. Pulse oximetry reveals an oxygen saturation of 58%. The infant appears cyanotic and lethargic.

An emergency echocardiogram reveals d-transposition of the great arteries with intact ventricular septum and a restrictive foramen ovale. Prostaglandin E1 is initiated, and the infant undergoes emergency balloon atrial septostomy. Arterial blood gas reveals a profound metabolic acidosis. A preoperative brain MRI demonstrates white matter injury.

The infant undergoes an arterial switch operation on day of life six. He survives but is subsequently diagnosed with developmental delay, speech and language impairment, and difficulties with executive function.

This vignette illustrates a number of issues that commonly arise in d-TGA litigation, including the subtlety of early clinical findings, the role of pulse oximetry screening, the consequences of delayed diagnosis, and the question of whether earlier recognition would have changed the outcome. Each of these topics is discussed in the sections that follow.

Understanding d-Transposition of the Great Arteries

To evaluate a case involving d-TGA, attorneys must first understand the nature of the defect, how it differs from normal cardiac anatomy, and why it is life-threatening without intervention.

Normal cardiac anatomy

In the normal heart, the right ventricle pumps deoxygenated blood through the pulmonary artery to the lungs, where it picks up oxygen. Oxygenated blood then returns to the left atrium and is pumped by the left ventricle through the aorta to the body. This creates a circuit in which the pulmonary (lung) and systemic (body) circulations are connected in series — blood flows from the body to the lungs and back to the body again.

d-TGA anatomy

In d-TGA, the two great arteries are transposed — that is, they arise from the wrong ventricles. The aorta originates from the right ventricle, and the pulmonary artery originates from the left ventricle. The connections between the atria and ventricles remain normal (concordant atrioventricular connections), but the connections between the ventricles and great arteries are reversed (discordant ventriculoarterial connections).

This anatomic arrangement creates two parallel circuits rather than the normal series circuit. Deoxygenated blood returning from the body enters the right atrium, passes to the right ventricle, and is pumped directly back to the body through the aorta — without ever passing through the lungs for oxygenation. Simultaneously, oxygenated blood returning from the lungs enters the left atrium, passes to the left ventricle, and is pumped back to the lungs through the pulmonary artery — without ever reaching the body.

This parallel circulation is incompatible with life unless there is some communication — a "mixing point" — between the two circuits that allows oxygenated and deoxygenated blood to mix.

Sources of mixing

Three potential mixing points exist in the newborn:

• The foramen ovale, a normal opening between the right and left atria present in fetal life, which typically begins to close after birth.
• The ductus arteriosus, a normal fetal blood vessel connecting the aorta and pulmonary artery, which also typically closes within the first days of life.
• A ventricular septal defect (VSD), a hole between the right and left ventricles, which is present in approximately one-third of d-TGA cases.

In the roughly two-thirds of d-TGA patients who have an intact ventricular septum — no VSD — the foramen ovale and ductus arteriosus are the only avenues for mixing. As these structures close during normal neonatal transition, mixing decreases, oxygen levels fall, and the infant develops progressive and potentially fatal cyanosis. This is why d-TGA is classified as a ductal-dependent lesion: the infant's survival depends on maintaining an open ductus arteriosus until definitive treatment can be performed.

Natural history

Without surgical intervention, the natural history of d-TGA is dire. Fewer than 10% of infants with d-TGA survive to six months of age without treatment. Death typically results from profound hypoxemia (inadequate oxygen delivery to the tissues) and subsequent metabolic acidosis, multi-organ failure, and cardiovascular collapse.

Embryology

d-TGA results from abnormal development of the conotruncal region of the embryonic heart. During normal cardiac development, the outflow tract undergoes a complex process of septation and rotation that results in the aorta connecting to the left ventricle and the pulmonary artery connecting to the right ventricle. In d-TGA, this rotational process is disrupted — the precise mechanism remains incompletely understood — resulting in the great arteries arising from the incorrect ventricles. The etiology is multifactorial, involving genetic, epigenetic, and environmental factors. d-TGA is typically an isolated anomaly, occurring without a recognizable genetic syndrome in the majority of cases.

Prenatal Diagnosis

The opportunity to diagnose d-TGA before birth represents a critical clinical milestone, because prenatal diagnosis allows for planned delivery at a specialized center, immediate postnatal stabilization, and avoidance of the hemodynamic crises that can occur when the diagnosis is made after the infant has already deteriorated.

Routine fetal anatomy ultrasound

In the United States, pregnant women typically undergo a second-trimester fetal anatomy ultrasound between 18 and 22 weeks of gestation. This examination includes evaluation of fetal cardiac anatomy. However, the ability to detect d-TGA on prenatal ultrasound depends critically on which cardiac views are obtained.

The four-chamber view — the most widely used screening view — typically appears normal in d-TGA because the chambers, valves, and ventricular size are usually normal. Detection of d-TGA requires visualization of the outflow tracts, specifically the three-vessel and trachea view, which demonstrates the relationship between the great arteries. When outflow tract views are included in the screening protocol, the two great arteries can be seen arising in parallel from their respective ventricles rather than crossing over each other as in the normal heart.

Prenatal detection rates

Historically, prenatal detection rates for d-TGA were low. Population-based data from Alberta, Canada, demonstrated that prenatal detection of d-TGA improved from 14% in 2003–2010 to 50% in 2011–2013 and to 77% in 2014–2015, temporally associated with updated obstetric ultrasound guidelines that incorporated outflow tract screening. An abnormal or poorly visualized outflow tract with a normal four-chamber view was the indication for fetal echocardiography referral in 98% of prenatally detected cases. Data from the Czech Republic similarly demonstrated that prenatal detection rates for TGA increased to approximately 70% by 2021, and a Danish center reported prenatal detection rates of 82% between 2015 and 2018.

When a screening ultrasound raises suspicion, the patient is referred for a formal fetal echocardiogram, typically performed by a pediatric cardiologist or maternal-fetal medicine specialist using specialized equipment and protocols. This targeted examination can confirm the diagnosis and identify associated defects.

Limitations

Despite improving detection rates, prenatal diagnosis of d-TGA is not achieved in all cases. The four-chamber view may appear entirely normal, and outflow tract views can be technically challenging to obtain due to fetal position, maternal body habitus, gestational age, or operator experience. Even in centers with high detection rates, some cases are missed. In Massachusetts, prenatal detection of CCHD overall increased from 46% in 2004 to 76% by 2018.

Not every missed prenatal diagnosis represents substandard care. The medicolegal analysis of a missed prenatal diagnosis must consider whether the accepted standard of practice at the time and location included outflow tract screening, whether the sonographer obtained adequate views, whether findings that should have prompted further evaluation were present, and whether the sonographer and interpreting physician met the training and credentialing expectations for the examination.

Postnatal Recognition

For infants whose d-TGA is not diagnosed prenatally — which historically has represented the majority of cases and still accounts for a significant minority — the clinical presentation after birth represents the next opportunity for diagnosis.

Cyanosis

The hallmark clinical finding in d-TGA is cyanosis — a bluish discoloration of the skin, lips, and mucous membranes caused by inadequate oxygen levels in the blood. In d-TGA with intact ventricular septum, cyanosis is typically present from birth, though it may initially be subtle or intermittent, particularly if the foramen ovale and ductus arteriosus are providing adequate mixing.

Cyanosis becomes clinically visible to the naked eye when deoxygenated hemoglobin reaches approximately 4–5 grams per deciliter, which generally corresponds to an oxygen saturation of approximately 80% or below. Importantly, cyanosis can be particularly difficult to detect by visual inspection alone in infants with darker skin pigmentation, making objective measurement with pulse oximetry essential.

As the ductus arteriosus and foramen ovale begin to close in the hours to days after birth, mixing decreases and cyanosis worsens — often dramatically. The infant may progress from appearing only mildly dusky to profoundly cyanotic and critically ill over a matter of hours.

Other clinical findings

Beyond cyanosis, infants with d-TGA may present with:

• Tachypnea (rapid breathing), which represents the body's attempt to compensate for low oxygen levels.
• Feeding difficulty, as the work of breathing and decreased oxygen delivery impair the infant's ability to coordinate sucking, swallowing, and breathing.
• Poor weight gain in cases where diagnosis is delayed beyond the first few days.
• Irritability or lethargy as oxygen deprivation affects the central nervous system.

Physical examination

The physical examination findings in d-TGA can be deceptively subtle, which is one of the reasons the diagnosis is sometimes missed. Key examination features include:

• The second heart sound is typically single and loud, because the aorta is positioned anteriorly and the aortic valve closure is accentuated. However, this finding is subtle and easily overlooked.
• A heart murmur is often absent. Unlike many other congenital heart defects, d-TGA with intact ventricular septum typically does not produce a significant murmur because there is no ventricular-level communication creating turbulent blood flow. This is a critical point: the absence of a murmur does not exclude serious congenital heart disease.
• The precordium may feel hyperdynamic.

The combination of subtle examination findings and the potential for the infant to initially appear "well" — particularly in the first hours of life when the ductus arteriosus remains open — creates a dangerous window during which the diagnosis can be missed.

Differential diagnosis

Other conditions that can produce neonatal cyanosis include persistent pulmonary hypertension of the newborn, respiratory distress syndrome, pneumonia, sepsis, and other cyanotic congenital heart defects such as tetralogy of Fallot, total anomalous pulmonary venous return, truncus arteriosus, and tricuspid atresia. The key clinical distinction is that cyanosis caused by heart disease typically does not improve significantly with supplemental oxygen (the hyperoxia test), whereas respiratory causes of cyanosis often do. Any newborn with persistent cyanosis or oxygen saturations below 95% requires urgent evaluation to distinguish cardiac from non-cardiac etiologies.

Pulse Oximetry Screening

Pulse oximetry screening for critical congenital heart disease (CCHD) has become a cornerstone of newborn care and is one of the most important elements in the evaluation of delayed d-TGA diagnosis cases.

Rationale

The rationale for universal pulse oximetry screening is straightforward: many forms of CCHD, including d-TGA, may not produce clinically obvious signs before the infant is discharged from the birth hospital. Cyanosis can be subtle, murmurs can be absent, and physical examination alone is insufficient to detect all cases. Pulse oximetry provides an objective, noninvasive measurement of blood oxygen saturation that can identify hypoxemia before it is clinically apparent to the eye.

Recommended Uniform Screening Panel

In September 2011, CCHD screening was added to the United States Recommended Uniform Screening Panel (RUSP) with the endorsement of the American Academy of Pediatrics (AAP), the American College of Cardiology Foundation, and the American Heart Association. CCHD is defined as a subset of congenital heart defects with a high likelihood of presenting with hypoxemia and requiring intervention in the first year of life. The primary targets of screening include d-TGA, hypoplastic left heart syndrome, pulmonary atresia, tetralogy of Fallot, total anomalous pulmonary venous return, tricuspid atresia, and truncus arteriosus, among others.

State implementation

Following the 2011 RUSP recommendation, individual states implemented CCHD screening policies through legislation or regulation. By August 2016, 48 states had enacted such policies, and by July 2018, all states and territories had adopted CCHD screening. Implementation of mandatory pulse oximetry screening has been associated with a significant reduction in early infant cardiac deaths. A 2017 study published in JAMA found that states implementing mandatory screening policies experienced a 33.4% reduction in cardiac deaths between 24 hours and 6 months of age compared to states without such policies.

Screening algorithm

The current AAP screening algorithm, updated in a 2025 clinical report, includes the following key elements:

• Screening should be performed at 24 hours of age or as late as possible before discharge if the infant is discharged before 24 hours.
• Oxygen saturation is measured in both the right hand (pre-ductal) and either foot (post-ductal).
• A passing result requires SpO2 of 95% or greater in both measurements.
• A failing result, with SpO2 below 90% in either measurement, requires immediate evaluation.
• An indeterminate result — SpO2 of 90–94% in either measurement or greater than 3% difference between pre- and post-ductal measurements — triggers one retest within one hour. The updated algorithm reduced the number of retests from two to one, simplifying the protocol and reducing the time to definitive evaluation.
• Any infant who fails the retest should undergo echocardiography and clinical evaluation.

Sensitivity and specificity

A Cochrane systematic review analyzing 19 studies with 436,758 neonates found that pulse oximetry screening using a threshold of 95% or below had a pooled sensitivity of 76.3% and specificity of 99.9% for detecting CCHD. The false-positive rate after 24 hours of life was very low, approximately 0.06%. However, it is critically important to understand that the sensitivity of pulse oximetry varies substantially by lesion type. For defects that reliably produce hypoxemia — such as d-TGA with intact ventricular septum — the detection rate is relatively high. For lesions such as coarctation of the aorta, which may not produce significant desaturation in the newborn period, sensitivity can be as low as 21%. The most recent AAP data estimate overall sensitivity at 50–76%.

Limitations

Pulse oximetry screening is only one component of a comprehensive strategy for detecting CCHD. It has several important limitations:

• A normal pulse oximetry screen does not exclude congenital heart disease. Some lesions do not produce hypoxemia, and even hypoxemia-producing lesions may not be detected if screening occurs while adequate mixing is still present.
• The timing of the screen matters. If performed very early, before the ductus arteriosus begins to close, saturations may be falsely reassuring.
• Accuracy of pulse oximetry in detecting hypoxemia may differ based on skin pigmentation, an area of active study.
• In neonates with d-TGA who have a large atrial septal defect or VSD providing adequate mixing, saturations may initially be in the passing range, only to deteriorate later.

These limitations underscore that a passing pulse oximetry screen should never be used as the sole basis for concluding that an infant does not have congenital heart disease. All stakeholders should understand that pulse oximetry is a screening test — not a diagnostic test — and must be interpreted in the context of the complete clinical picture.

Documentation

From a medicolegal perspective, documentation of pulse oximetry screening is essential. The screening should be documented with: the time and date of the screen, the specific pre-ductal and post-ductal saturation values, the result interpretation (pass, fail, or indeterminate), and any follow-up actions taken. The absence of any documentation of pulse oximetry screening in the medical record may be a significant issue in cases of delayed d-TGA diagnosis, particularly when screening was required by state law or hospital policy.

Diagnostic Evaluation

Once cyanosis or hypoxemia is identified, a series of diagnostic and therapeutic steps should follow in rapid sequence.

Echocardiography

Echocardiography is the definitive diagnostic test for d-TGA. A transthoracic echocardiogram performed by a trained sonographer can confirm the diagnosis, define the exact cardiac anatomy including associated defects, assess the size and restrictiveness of the foramen ovale, evaluate ventricular function, and guide decisions about further management. In the setting of suspected cyanotic congenital heart disease, echocardiography should be obtained emergently. The American Society of Echocardiography has published recommendations for echocardiographic evaluation in this setting, including guidance for adult cardiac sonographers who may be called upon to perform or interpret these studies in community hospital settings where pediatric-trained sonographers may not be immediately available.

Chest radiography

The classic chest radiograph appearance in d-TGA has been described as an "egg on a string" — an egg-shaped cardiac silhouette with a narrow superior mediastinum created by the parallel relationship of the transposed great arteries. However, this finding is often absent. One study found that the majority of neonates with d-TGA failed to demonstrate the classic radiographic findings, and a normal chest radiograph was the most common presenting scenario. Therefore, a normal chest radiograph does not exclude d-TGA.

Electrocardiography

The ECG in a newborn with d-TGA typically shows right axis deviation and right ventricular hypertrophy, findings that are normal in the neonatal period. The ECG is therefore of limited diagnostic utility for d-TGA in the newborn.

Arterial blood gas

An arterial blood gas (ABG) is critical for assessing the severity of hypoxemia and metabolic acidosis. A low partial pressure of oxygen (PaO2) and elevated lactate level indicate significant tissue oxygen debt and have prognostic implications. The degree and duration of metabolic acidosis are relevant to causation analysis in medicolegal cases, as they reflect the severity and chronicity of oxygen deprivation.

The hyperoxia test — measuring PaO2 while the infant breathes 100% oxygen — can help distinguish cardiac from pulmonary causes of cyanosis. In d-TGA, the PaO2 typically fails to rise above 100 mmHg despite 100% supplemental oxygen, because the underlying problem is not a lung disease but rather a structural cardiac defect preventing oxygenated blood from reaching the systemic circulation.

Prostaglandin E1

Prostaglandin E1 (PGE1, alprostadil) is the initial medical therapy for suspected ductal-dependent congenital heart disease. It acts by maintaining patency of the ductus arteriosus, thereby preserving a communication between the pulmonary and systemic circulations and allowing some degree of mixing. PGE1 should be initiated as soon as a ductal-dependent lesion is suspected — ideally before confirmatory echocardiography. The side effects of PGE1 include apnea, fever, and hypotension, but these are generally manageable in a monitored setting. Delayed initiation of PGE1 is a common allegation in d-TGA litigation.

Balloon atrial septostomy

When mixing through the foramen ovale is inadequate — as evidenced by persistent severe hypoxemia despite PGE1 — a balloon atrial septostomy (BAS, also known as the Rashkind procedure) is performed emergently. This catheter-based procedure involves advancing a balloon catheter through the foramen ovale and inflating and pulling it back to enlarge the opening between the atria, thereby improving mixing of oxygenated and deoxygenated blood. BAS is typically performed at the bedside using echocardiographic guidance or in the cardiac catheterization laboratory.

Transfer

Infants diagnosed with d-TGA at a community hospital require urgent transfer to a tertiary pediatric cardiac center with capabilities for neonatal cardiac surgery. The AHA classifies d-TGA as a Level 3 delivery, defined as a condition where the neonate is likely to require immediate specialty cardiac care and should ideally be delivered at or rapidly transferred to a center with these capabilities. The quality and timeliness of the transfer — including appropriate stabilization before and during transport, continuation of PGE1, and communication between referring and receiving teams — are frequently relevant issues in medicolegal review.

Medical Considerations in Evaluating Standards of Care

When physicians serve as expert witnesses or consultants in d-TGA cases, they typically evaluate the care provided against current evidence-based recommendations and widely accepted clinical practices. The following medical issues are commonly assessed.

It is important to distinguish medical standards — what current evidence and guidelines recommend — from legal standards of care, which are jurisdiction-specific and determined by the courts. Medical experts inform the legal analysis, but the ultimate determination of whether care met the applicable legal standard is a legal question.

Recognition of abnormal clinical findings

A central issue in many d-TGA cases is whether the clinical findings that were present should have prompted further evaluation. Cyanosis, tachypnea, poor feeding, and oxygen desaturation are the cardinal signs of cyanotic congenital heart disease in the newborn. While these findings can occur in other conditions, they should never be dismissed without an adequate diagnostic evaluation. Medical experts commonly evaluate whether the documented clinical findings, taken together, should have raised concern for congenital heart disease and whether the clinical response was appropriate.

Response to cyanosis

Any documented episode of cyanosis in a newborn should trigger measurement of oxygen saturation and, if the saturation is abnormal, a systematic evaluation to determine the cause. A common issue in delayed diagnosis cases is whether cyanosis was observed but not objectively assessed, assessed but not correctly interpreted, or correctly interpreted but not acted upon in a timely manner.

Pulse oximetry screening

As discussed above, pulse oximetry screening has been the standard of care in the United States since its inclusion on the RUSP in 2011 and its adoption by all states by 2018. Common issues include whether screening was performed, whether it was performed correctly (proper timing, correct sites, appropriate interpretation), whether the results were properly documented, and whether abnormal results were appropriately acted upon.

Escalation and consultation

When a newborn presents with findings concerning for congenital heart disease, the medical standard calls for timely consultation with a pediatric cardiologist and arrangement for echocardiography. Delays in obtaining cardiology consultation or echocardiography are frequently evaluated in the medicolegal context. The expected time to consultation and imaging depends on the clinical setting and available resources, but the urgency of the clinical scenario should drive the timeline.

Communication

Effective communication among the healthcare providers involved in the care of the newborn — including obstetricians, nurses, pediatricians, neonatologists, and cardiologists — is a fundamental expectation. Failures in handoff communication, including failure to communicate abnormal vital signs between nursing and physician staff, can contribute to delayed diagnosis.

Documentation

The medical record is the primary evidence source in any medicolegal case. Complete, accurate, and contemporaneous documentation of clinical findings, vital signs, pulse oximetry results, clinical reasoning, and actions taken is essential. Gaps in documentation, inconsistencies between nursing and physician notes, and absence of recorded pulse oximetry values are commonly evaluated issues.

Transfer decisions

For infants diagnosed at a community hospital, the timeliness and appropriateness of transfer to a pediatric cardiac center are frequently at issue. Relevant considerations include the time elapsed between diagnosis and transfer, the stabilization measures undertaken before transport, and the mode and quality of transport.

Common Allegations in Litigation

d-TGA cases in litigation frequently involve one or more of the following allegations. Each is discussed from a medical perspective.

Failure to recognize cyanosis

The allegation that clinical signs of cyanosis were present but not recognized or not acted upon is among the most common. As noted above, cyanosis in d-TGA can initially be subtle and may be attributed to benign causes such as acrocyanosis (bluish discoloration of the hands and feet, which is normal in newborns). However, central cyanosis — involving the lips, tongue, and trunk — is always abnormal and requires immediate evaluation.

Omitted pulse oximetry screening

The failure to perform mandated pulse oximetry screening before discharge represents a clear departure from current practice standards. Whether this omission constituted a deviation from the legal standard of care in a given jurisdiction depends on the applicable law and hospital policies at the time.

Incorrect interpretation of pulse oximetry

Cases may involve pulse oximetry values that were obtained but misinterpreted. For example, a saturation of 92% in a newborn is not normal and should trigger further evaluation under the current screening algorithm. However, clinical staff who are unfamiliar with the screening protocol may incorrectly accept such values as within normal limits.

Delayed echocardiography

Once concern for congenital heart disease exists, echocardiography should be obtained emergently. Delays in arranging or performing echocardiography may contribute to prolonged periods of hypoxemia and worsening clinical status.

Delayed cardiology consultation

Timely involvement of a pediatric cardiologist is essential for appropriate management of suspected cyanotic congenital heart disease. In community hospital settings where a pediatric cardiologist is not immediately available, telemedicine consultation and arrangements for transfer should be initiated promptly.

Delayed prostaglandin administration

Initiation of PGE1 should not be delayed while awaiting echocardiographic confirmation of the diagnosis. In a critically hypoxemic newborn with suspected ductal-dependent congenital heart disease, PGE1 should be started empirically based on the clinical presentation.

Delayed transfer

Unnecessary delays in transferring a critically ill newborn to a facility capable of providing definitive care can result in additional organ injury. The timing, coordination, and clinical management during transport are all relevant.

Documentation deficiencies

Incomplete or absent documentation of pulse oximetry screening, clinical assessments, vital signs, or clinical decision-making can undermine the defense of care that was actually appropriate and can make it impossible to reconstruct the clinical timeline.

It is essential to evaluate each allegation in the context of the specific clinical circumstances, the available resources, the prevailing standards at the time the care was rendered, and the individual patient's presentation. A finding that is obvious in retrospect may not have been apparent at the time, and medical experts must carefully distinguish hindsight bias from genuine deviation from the standard of care.

Medical Causation

Establishing causation — the link between the alleged deviation from standard of care and the harm suffered — is one of the most complex aspects of d-TGA litigation. A thorough causation analysis must address several key questions.

Hypoxemia and its consequences

The fundamental mechanism of injury in delayed d-TGA diagnosis is prolonged hypoxemia. When the brain, heart, and other organs are deprived of adequate oxygen, a cascade of injury occurs. Metabolic acidosis develops as tissues switch from aerobic to anaerobic metabolism, producing lactic acid. If hypoxemia is severe and prolonged, irreversible cellular injury and death can occur.

The organs most vulnerable to hypoxemic injury include:

• The brain, which is exquisitely sensitive to oxygen deprivation. Hypoxic-ischemic brain injury can result in white matter injury (periventricular leukomalacia), stroke, and global brain damage, with downstream effects on motor function, cognition, language, and behavior.
• The heart itself, where prolonged hypoxemia and acidosis can impair ventricular function and contribute to myocardial injury.
• The kidneys, liver, and gastrointestinal tract, which can all sustain hypoxic injury.

Neurological injury

Brain injury is the most significant long-term consequence of delayed d-TGA diagnosis. Preoperative brain injury — primarily white matter injury — has been documented on MRI in 24–48% of neonates with d-TGA, with higher rates observed in postnatally diagnosed infants compared to those diagnosed prenatally (48% vs. 24% in one multicenter study). The mechanism is believed to involve direct hypoxic-ischemic injury to vulnerable immature oligodendrocytes in the developing brain, compounded by the brain immaturity that is increasingly recognized as a feature of many forms of congenital heart disease.

In addition, complications of treatment itself — such as stroke during balloon atrial septostomy or brain injury related to cardiopulmonary bypass during surgery — must be considered in causation analysis. Not all neurological injury in d-TGA patients is attributable to delayed diagnosis; some injury may be related to the inherent risks of the condition and its treatment.

Timing analysis

A causation analysis in d-TGA cases typically requires a detailed reconstruction of the clinical timeline, including:

• When the earliest signs or symptoms of the defect were or should have been evident.
• When the diagnosis would have been made with timely evaluation.
• How the clinical course would have differed with earlier diagnosis and treatment.
• Whether the specific complications experienced by the patient would have been avoided or mitigated with earlier intervention.

This analysis must account for the fact that even with the most timely diagnosis and optimal care, d-TGA carries inherent risks. Some degree of preoperative brain injury is common even in prenatally diagnosed infants, and surgical complications can occur regardless of timing.

Probability versus possibility

Medical causation in the legal context typically requires the expert to opine to a reasonable degree of medical probability — that is, more likely than not (greater than 50% probability) — that the deviation from care caused or contributed to the harm. A finding that an injury was merely possible is generally insufficient. The expert must articulate the pathophysiologic mechanism linking the delay to the specific injury and explain why the injury would more probably than not have been avoided with timely care.

Preventability

Not all adverse outcomes in d-TGA are preventable. Even with optimal care, some children with d-TGA will have neurodevelopmental challenges, require reintervention, or experience complications. The question is whether earlier diagnosis and treatment would have, to a reasonable degree of medical probability, prevented or reduced the specific injuries at issue.

Long-Term Outcomes

Understanding the expected long-term outcomes after d-TGA repair is essential for assessing both the baseline risks of the condition and the incremental harm that may result from delayed diagnosis.

Arterial switch operation

The arterial switch operation (ASO) has been the standard surgical repair for d-TGA since the late 1980s. It involves transecting both great arteries above their respective valves and reconnecting them to the appropriate ventricles — the aorta to the left ventricle and the pulmonary artery to the right ventricle. The coronary arteries must also be transferred from the native aortic root to the neo-aortic root. The ASO restores normal (or near-normal) anatomy, with the left ventricle serving as the systemic ventricle.

Survival

Modern surgical mortality for the ASO is less than 4%, and in high-volume centers, it is below 2%. A 2026 multicenter study of 1,125 patients who underwent ASO between 1990 and 2015 demonstrated survival of 91.3% at 10 years, 90.7% at 20 years, and 88.9% at 30 years. A scoping systematic review including over 30,000 participants found pooled short-term survival of 92%, medium-term survival of 90%, and long-term survival beyond 20 years of 87%. The most common long-term complications include right ventricular outflow tract or pulmonary artery obstruction (requiring reintervention in approximately 12% of patients), neoaortic root dilation, and neoaortic valve regurgitation. Coronary artery complications, once a major concern, now occur in fewer than 3% of cases.

Timing of surgery

The optimal timing of the ASO is generally within the first week of life for d-TGA with intact ventricular septum. A large multicenter analysis of 3,523 neonates found that ASO performed after 7 days of life was associated with an odds ratio of 1.79 (95% CI: 1.13–2.82) for the composite outcome of death or need for postoperative extracorporeal membrane oxygenation (ECMO). One study found that the lowest probability of major morbidity occurred around day 3 of life, with progressively increasing risk with further delay. Earlier age at surgery has also been associated with better brain growth and language development.

Neurodevelopment

Neurodevelopmental outcomes represent the most significant area of long-term concern for children with d-TGA. The landmark Boston Circulatory Arrest Study followed d-TGA patients after ASO at 1, 4, 8, and 16 years of age and documented that, while mean intelligence quotients were close to normal, the cohort as a whole underperformed relative to normative populations in multiple domains: visual-spatial and visual-memory skills, executive functioning, working memory, sustained attention, and higher-order language skills. At age 16, 65% of patients were receiving remedial academic or behavioral services, one-third had brain abnormalities on MRI, and patients were four times more likely to be taking psychotropic medications compared with cardiovascular medications.

These findings have been confirmed across multiple centers worldwide. The 2024 AHA scientific statement on neurodevelopmental outcomes in congenital heart disease notes that postnatal diagnosis of TGA is associated with greater risk for preoperative brain injury and worse neurodevelopmental outcomes compared with prenatal diagnosis. In children with prolonged cyanosis, older age at repair has been associated with lower IQ, with the greatest impact on perceptual motor function. These data have clear implications for causation analysis in delayed diagnosis cases.

The AHA recommends neurodevelopmental evaluation for all children with d-TGA, ideally beginning in early childhood, with ongoing surveillance as new challenges may emerge with increasing academic and social demands.

Exercise capacity and quality of life

Most children and adults after ASO have good functional capacity, though exercise tolerance may be mildly reduced compared with age-matched peers. Quality of life assessments in adolescents after ASO have generally been favorable, though adults with d-TGA face increased rates of anxiety and depression, with an estimated lifetime prevalence of approximately 50% — far exceeding that of the general population.

Lifelong follow-up

All patients with d-TGA require lifelong follow-up with a cardiologist experienced in congenital heart disease. The ACC/AHA guidelines recommend regular surveillance for late complications including coronary artery abnormalities, neoaortic root dilation and regurgitation, pulmonary artery stenosis, arrhythmias, and ventricular dysfunction. The need for reintervention persists throughout the lifespan.

Medical Records That Often Matter

In evaluating a potential d-TGA case, certain categories of medical records are particularly important.

• Prenatal records. The obstetric record, including documentation of prenatal ultrasound examinations, is essential for determining whether the defect could or should have been detected before birth. Specific attention should be paid to the ultrasound report's description of fetal cardiac views — were outflow tract views obtained? Were any cardiac views described as suboptimal or limited? Was the patient referred for fetal echocardiography?
• Fetal imaging. If a fetal echocardiogram was performed, the report and, if available, the stored images should be reviewed. If no fetal echocardiogram was performed, the question is whether one should have been ordered based on the findings of the screening ultrasound.
• Nursery and delivery documentation. The birth hospital record contains critical information, including Apgar scores, initial vital signs, nursing assessments describing the infant's color and feeding behavior, and any notations regarding clinical concerns in the first hours and days of life.
• Nursing notes. Nursing notes are often the most detailed source of real-time clinical observations. They may contain descriptions of color changes, feeding difficulties, or saturation readings that were not subsequently acted upon by the physician.
• Pulse oximetry records. Documentation of newborn pulse oximetry screening — including the specific pre-ductal and post-ductal saturation values, the timing of the screen, the interpretation, and any follow-up actions — is critically important. The complete absence of pulse oximetry documentation may be significant.
• Emergency department records. If the infant presented to an emergency department after discharge, these records document the clinical condition at presentation, the initial vital signs and saturation values, the evaluation performed, and the time to definitive diagnosis and treatment.
• Transport records. Records from neonatal transport teams document the infant's clinical status during transfer, medications administered (including PGE1), vital signs en route, and communication with the receiving facility.
• Echocardiography reports. The echocardiographic report confirms the cardiac anatomy and provides baseline functional data. The timing of echocardiography relative to the onset of symptoms is relevant to the question of whether the evaluation was appropriately expedited.
• Operative reports. Surgical reports document the anatomy encountered, the procedure performed, and any intraoperative complications. They may also reference the preoperative clinical status of the infant.
• ICU records. Intensive care unit records provide detailed data on the infant's postoperative course, including hemodynamic stability, need for mechanical support, organ function, and neurological status.
• Outpatient follow-up. Records of long-term follow-up document the neurodevelopmental trajectory, cardiac status, reinterventions, and functional outcomes that form the basis of damages assessment.

Common Misconceptions

Several misconceptions can lead to errors in the evaluation of d-TGA cases — both in clinical practice and in the legal arena.

"The baby looked normal, so there could not have been a heart problem." This is perhaps the most dangerous misconception in neonatal medicine. Many forms of serious congenital heart disease, including d-TGA, can present with a deceptively well-appearing infant in the first hours to days of life. The absence of obvious distress does not exclude a life-threatening cardiac defect. This is precisely the reason why objective pulse oximetry screening was introduced — because clinical appearance alone is insufficient.

"There was no heart murmur, so the heart was normal." d-TGA with intact ventricular septum typically produces no murmur because there is no abnormal flow across a ventricular septal defect. A single loud second heart sound may be the only auscultatory abnormality. The absence of a murmur provides no reassurance whatsoever against d-TGA.

"The pulse oximetry screen was normal, so the baby does not have heart disease." A passing pulse oximetry screen substantially reduces but does not eliminate the possibility of CCHD. The AAP explicitly states that CCHD should not be ruled out based on pulse oximetry alone. Furthermore, the timing of the screen matters — an early screen performed while the ductus arteriosus is widely patent may yield a falsely reassuring result.

"A delayed diagnosis always changes the outcome." This is an important misconception to address from both the plaintiff and defense perspectives. While there is strong evidence that delayed diagnosis increases the risk of adverse outcomes — including brain injury, need for more urgent and complicated interventions, and worse neurodevelopmental outcomes — it is not the case that every delayed diagnosis results in additional harm. Some infants diagnosed late may still achieve excellent outcomes, and some infants diagnosed early may still experience complications. The causation analysis must evaluate the specific clinical circumstances of the individual case.

The Value of Pediatric Cardiology Expertise

d-TGA cases involve a degree of medical complexity that typically requires review by a physician with specialized training and experience in pediatric and congenital cardiology. The key areas of expertise include:

• Congenital cardiac anatomy. Understanding the precise anatomic variants of d-TGA — including the presence or absence of associated defects such as ventricular septal defect, left ventricular outflow tract obstruction, and coronary artery variants — is essential for interpreting the clinical presentation, surgical decision-making, and expected outcomes.
• Neonatal physiology. The transitional physiology of the newborn — including ductal closure, changes in pulmonary vascular resistance, and the dynamics of intracardiac mixing — directly determines the clinical trajectory of an infant with d-TGA and must be understood in evaluating the timeline of clinical deterioration.
• Fetal diagnosis. Evaluating whether d-TGA should have been detected on prenatal ultrasound requires expertise in fetal cardiac imaging, including knowledge of the specific views required, the technical limitations, and the detection rates reported in the literature.
• Pediatric cardiac imaging. Interpretation of echocardiographic findings, MRI data, and catheterization results requires familiarity with the unique features of congenital heart disease imaging.
• Current clinical guidelines. The standards of care for d-TGA — including screening, initial stabilization, medical management, surgical timing, and long-term follow-up — are defined by guidelines from the AHA, AAP, ACC, and other professional societies. An expert must be current with these recommendations to render an opinion on whether the care provided met accepted standards.
• Causation analysis. Linking a delay in diagnosis to specific clinical outcomes requires not only knowledge of the pathophysiology of hypoxemic injury but also familiarity with the published literature on outcomes — including the expected rates of neurodevelopmental impairment, the impact of prenatal versus postnatal diagnosis, and the effect of surgical timing on results. This specialized knowledge is essential for providing a credible and objective causation opinion.

Key Takeaways for Attorneys

1. d-TGA creates two parallel circulations that are incompatible with life without mixing between the systemic and pulmonary circuits. This makes early diagnosis and intervention essential.
2. Pulse oximetry screening has been the standard of care throughout the United States since 2018, and was recommended by major professional societies beginning in 2011. Failure to perform or properly interpret newborn pulse oximetry screening is a significant medical issue in delayed diagnosis cases.
3. The absence of a heart murmur does not exclude d-TGA. In fact, d-TGA with intact ventricular septum typically produces no murmur. Reliance on the absence of a murmur to exclude heart disease represents a fundamental misunderstanding of the condition.
4. A normal-appearing newborn may have d-TGA. Clinical appearance alone is insufficient for detection, and objective testing with pulse oximetry and, when indicated, echocardiography is required.
5. Prenatal detection of d-TGA has improved significantly but remains imperfect. Not every missed prenatal diagnosis constitutes substandard care, but the evaluation should consider whether appropriate cardiac screening views were attempted and whether findings that warranted further investigation were present.
6. Delayed diagnosis of d-TGA increases the risk of brain injury and adverse neurodevelopmental outcomes. The evidence linking prenatal versus postnatal diagnosis to differences in preoperative brain injury and childhood neurodevelopment is robust and well-documented.
7. Causation analysis must be individualized. The question is not simply whether the diagnosis was delayed, but whether earlier diagnosis would have, to a reasonable degree of medical probability, prevented or reduced the specific injuries experienced by the individual patient.
8. Medical standards and legal standards of care are related but distinct concepts. Medical experts can opine on what current evidence and guidelines recommend; the determination of whether care met the applicable legal standard is a question for the courts.
9. Not every adverse outcome is the result of substandard care. d-TGA carries inherent risks of neurological injury and surgical complications even with optimal management. Distinguishing preventable harm from unavoidable risk requires expert medical analysis.
10. Cases involving d-TGA require review by experts with specific training and experience in pediatric and congenital cardiology who can objectively evaluate the medical evidence without advocacy bias.